Lonza Pharma & Biotech and Denali Therapeutics (NASDAQ: DNLI) announced today an exclusive strategic partnership on Denali’s biologic pipeline products for neurodegenerative diseases. The agreement covers all stages of the development and manufacturing,
{iframe}https://www.lonza.com/about-lonza/media-center/news/Tensid/2018-02-08-14-00-English.aspx{/iframe}